Atlas Trials

Magnetic Resonance Tumour Regression Grade (mrTRG) as a Novel Biomarker - Phase III Non CTIMP Trial

Clinical trial NCT02704520 · RECRUITING

Trial details

NCT number
NCT02704520
Sponsor
Imperial College London
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2016-03-01
Primary completion
2026-12-01
Enrollment
441

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.